Skip to main content

Table 3 Toxicities by grade and causality in the newly diagnosed GBM patients treated with combined TTFields-Temozolomide.

From: Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)

  Grade Causality assessment
  I-II III-IV  
Elevated LFTs 6/10 0/10 Anti Epileptic Drugs
Hyperglycemia 4/10 0/10 Oral Steroids
Anemia 6/10 0/10 Temozolomide
Thrombocytopenia 2/10 0/10 Temozolomide
Leucopenia 3/10 0/10 Temozolomide
Headache 2/10 0/10 Underlying disease
Seizures 1/10 0/10 Underlying disease
Dermatitis 10/10 0/10 NovoTTF-100A